Market Place
Sourcing Support
Orchid Pharma Q2 FY25 PAT Up 26% with Strategic Initiatives
11 Nov 2024 //
INDPHARMAPOST
Orchid and Cipla collaborate to launch Cefepime-Enmetazobactam in India
29 Jun 2024 //
INDIANPHARMAPOST
Orchid Pharma appoints Rajnish Rohatgi as chief executive officer
19 Jun 2024 //
PHARMABIZ
Orchid Pharma receives DCGI approval for Cefepime and Enmetazobactam antibiotic
13 Jun 2024 //
BIOSPECTRUM ASIA
India’s DCGI approves Orchid Pharma’s API Enmetazobactam
06 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
Orchid Pharma gets DCGI approval to manufacture & market antibiotic drug combo
06 Jun 2024 //
PHARMABIZ
Orchid Pharma net profit declines 44 per cent in Q4FY24
24 May 2024 //
PHARMABIZ
Debt-free Orchid Pharma charts out growth plan
24 Apr 2024 //
ECONOMICTIMES
Orchid granted license to produce antibiotic to meet global need
12 Sep 2023 //
FIERCE PHARMA
Orchid Pharma enter tech transfer pact to make key cephalosporin intermediate
11 Jul 2023 //
ECONOMIC TIMES
Orchid Pharma Q4 FY23 consolidated PAT up at Rs. 59.13 Cr
11 May 2023 //
INDIAN PHARMA POST
Orchid Pharma board approves QIP programme to raise Rs 500 crore
01 Dec 2022 //
BUSINESS-STANDARD
Orchid Pharma antibiotic product for treating UTI coming to India: MD
25 Nov 2022 //
BUSINESS-STANDARD
Orchid Pharma reports positive EBIDTA in Q2
15 Nov 2022 //
INDIANPHARMAPOST
Sun Pharmaceutical bullish on Japanese market as peers lose interest
11 Nov 2019 //
BUSINESS STANDARD
Orchid Hlthcare’S Generic Risedronate SodiumApproval In US
16 May 2019 //
FDA
Divi’s, Gland, Fidelity enter race to buy Orchid Pharma
04 Mar 2019 //
ECONOMIC TIMES
Orchid Pharma’s lenders reject Union Quimico’s bid
23 Apr 2018 //
ECONOMIC TIMES
Orchid says US FDA has closed PADE inspection
09 Jan 2018 //
IN PHARMATECHNOLOGIST
Orchid Pharma gets EIR from USFDA for its Chennai facility
08 Jan 2018 //
ECONOMIC TIMES
PE funds, domestic pharma companies eye Orchid Pharma under IBC
25 Oct 2017 //
ECONOMIC TIMES
Pharma body Pharmexcil slams green groups` superbug charges
28 Oct 2016 //
ECONOMIC TIMES
Conspiracy to Defame Indian Pharma Globally is on: Pharmexcil
27 Oct 2016 //
ECONOMIC TIMES
Lobby links antibiotic to `dirty` drug factories Aurobindo is a culprit
20 Oct 2016 //
FIERCE PHARMA
Indian API makers, beset by Chinese imports, accuse officials of pulling $660M
06 Oct 2016 //
FIERCE PHARMA
Orchid Pharma net loss widens
15 Aug 2016 //
BUSINESS STANDARD
Orchid gets final nod from USFDA for Parkinson`s drug
16 Mar 2016 //
BUSINESS STANDARD
Anvisa releases import of inputs of Orchid Chemicals company
26 Jan 2016 //
ANVISA
Orchid Pharma gets favourable US FDA report for manufacturing unit
05 Jan 2016 //
BUSINESS STANDARD
Orchid Pharma gets EIR report from USFDA on inspection closure
01 Jan 2016 //
ECONOMIC TIMES
Orchid Pharma unit inks pact with UK entity for $800 mn loan
22 Dec 2015 //
ECONOMIC TIMES
Bulk drugs from China floods Indian market
11 Dec 2015 //
ECONOMIC TIMES
Chennai floods hit small drug factories, blow to US exports
08 Dec 2015 //
ECONOMIC TIMES
Global Drugs Market 2015-2019 with GSK,Helsinn,Heron,Merck & Tesaro Dominating
04 Nov 2015 //
PR NEWS WIRE
Orchid Chem gets FDA nod for anti-bacterial tablets
17 Jun 2015 //
FIRST WORD PHARMA
Most Pharma Cos Earn USFDA Wrath Over Data Integrity Issues
29 Dec 2014 //
THE TIMES OF INDIA
